Succession of Vernon James Goudeau - Affirmation of Lower Court Ruling

The Louisiana Court of Appeal, Third Circuit, affirmed a lower court's ruling in the Succession of Vernon James Goudeau. The appellate court found that the plaintiff failed to prove she was a forced heir and therefore not entitled to a portion of the estate.

Deutsche Bank v. Landry - Rehearing Denied

The Louisiana Court of Appeal, Third Circuit, denied the application for rehearing filed by Derinda R. Landry in the case of Deutsche Bank National Trust Company v. Derinda R. Landry. The judgment on rehearing was rendered and mailed on March 25, 2026.

Stanley v. Lafayette Police Department - Affirmation of Judgment

The Louisiana Court of Appeal affirmed a lower court's judgment in favor of the Lafayette Police Department and Scott Morgan. The case involved David Stanley, a former police union president, who appealed disciplinary actions related to his social media posts. The court found the exception of res judicata to be applicable.

State of Louisiana v. Sammy Cheatham - Sentencing Affirmation

The Louisiana Court of Appeal affirmed the sentences of Sammy Cheatham, who was convicted of attempted second-degree murder. The court noted a patent error in the sentencing, but the sentences were affirmed as imposed. Cheatham was sentenced to thirty years on each of seven counts, to run concurrently.

Colorado PUC Announces April Public Comment and Engagement Opportunities

The Colorado Public Utilities Commission (PUC) has announced public comment and engagement opportunities for April 2026. Key events include public comment hearings for Atmos Energy's proposed gas rate increase (Proceeding No. 25AL-0499G), which seeks an approximate $17.56 million increase in annual base rate revenues.

USPTO Patent Application for Compounds Targeting Pax3/Foxo1 Fusion Protein

The USPTO has published patent application US20260083724A1, filed by Georgetown University, for novel compounds designed to target the PAX3::FOXO1 fusion protein. These compounds aim to reduce protein levels and treat fusion-positive rhabdomyosarcoma.

Patent Application: Sigmari Ligand for Pancreatic Cancer Treatment

The USPTO has published a patent application (US20260083725A1) for a Sigmari Ligand for the treatment of pancreatic cancer. The application details a method involving a Sig-1R ligand to inhibit tumor growth and metastasis, filed on August 9, 2023.

Cancer Treatment Methods Using Tumor Treating Fields, Chemotherapy, and Anti-Fibrotic Agents

The USPTO has published a patent application detailing methods for treating cancer. The application describes compositions and systems involving the concurrent application of tumor treating fields, chemotherapeutic agents, and anti-fibrotic agents to reduce cancer cell viability and tumor growth.

Biopolymers for Ophthalmic Use Patent Application

The USPTO has published a patent application (US20260083771A1) for biopolymers intended for ophthalmic use, filed by ExoPolymer, Inc. The application details biopolymers comprising repeating polysaccharide units, their preparations, ophthalmic compositions, and methods of use.

Patent Application for Fiber-Based Prebiotic Dietary Supplements

The USPTO has published a patent application (US20260083772A1) for powder compositions comprising fiber intended for use as a prebiotic dietary supplement. The application details therapeutic ingredients and manufacturing processes aimed at improving gut microbiome and overall gut health.